Catalyst Pharmaceuticals Inc (CPRX)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 470,114 413,211 443,896 407,227 375,630 333,114 267,309 246,972 237,788 223,248 209,130 197,216 192,354 174,860 131,412 117,880 112,376 96,691 78,234 61,077
Total stockholders’ equity US$ in thousands 387,881 348,548 375,294 333,661 300,421 270,041 241,092 220,221 206,831 198,661 188,944 178,651 169,598 156,628 111,201 99,676 87,630 77,983 63,282 51,176
Financial leverage ratio 1.21 1.19 1.18 1.22 1.25 1.23 1.11 1.12 1.15 1.12 1.11 1.10 1.13 1.12 1.18 1.18 1.28 1.24 1.24 1.19

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $470,114K ÷ $387,881K
= 1.21

The financial leverage ratio of Catalyst Pharmaceuticals Inc has been fluctuating over the past few quarters. The ratio indicates the company's level of debt relative to its equity, with higher values suggesting higher financial leverage or dependency on debt financing.

Based on the data provided, the financial leverage ratio ranged from 1.10 to 1.28 over the last five quarters. The ratio peaked at 1.28 in the fourth quarter of 2019, indicating a higher level of debt compared to equity at that time. However, in the subsequent quarters, the ratio generally decreased, reaching a low of 1.10 in the second quarter of 2021.

Overall, Catalyst Pharmaceuticals Inc has maintained a moderate level of financial leverage, with fluctuations possibly driven by changes in debt levels or equity contributions. Investors and stakeholders may monitor this ratio to assess the company's ability to meet its financial obligations and the overall risk associated with its capital structure.